Dr. Heba Ismail

Dr. Paul J. Wolters specializes in the diagnosis and care of patients with interstitial lung disease, a category of disorders in which scarring of lung tissue affects breathing. Wolters is actively involved in research that aims to better understand the development of idiopathic pulmonary fibrosis, a type of interstitial lung disease. He is director of biological research for the UCSF Interstitial Lung Disease Program. Wolters received his medical degree from the University of Minnesota. He completed a residency in internal medicine at the University of Colorado, and a fellowship in pulmonary and critical care medicine at UCSF. He joined UCSF's division of pulmonary and critical care medicine in 1999. Dr. Wolters is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Pulmonary Fibrosis, and Lung Transplant. Dr. Wolters is board certified in American Board Of Internal Med/Critical Care Med, Critical Care Medicine and American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease. Dr. Wolters is currently accepting new patients.

Christopher Ryerson is a Pulmonary Medicine provider practicing medicine in San Francisco, California. Dr. Ryerson is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Pulmonary Fibrosis, Lung Transplant, and Endoscopy.

Dr. Laura Koth is a pulmonologist and an expert in interstitial lung disease. She is co-director of UCSF's interstitial lung disease center of excellence. Koth's research activities focus on the mechanisms of lung inflammation and macrophage activation. Macrophages are a type of white blood cell with important roles in immune response. Koth earned her medical degree from Harvard Medical School. She completed residency training in internal medicine at Massachusetts General Hospital, followed by a fellowship in pulmonary and critical care medicine UCSF. She joined the UCSF faculty in 2003. Dr. Koth is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Sarcoidosis, Hypersensitivity Pneumonitis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, and Lung Transplant. Dr. Koth is board certified in American Board Of Internal Med/Pulmonary Disease, Pulmonary Disease. Dr. Koth is currently accepting new patients.